Ophthalmological complications of the new coronavirus infection COVID-19. Clinical cases

Author:

Latypova E. A.1,Zagidullina A. Sh.1ORCID,Mukhamadeev T. R.2,Gizatullina M. A.3,Yamlikhanov A. G.4,Khairullina G. F.3

Affiliation:

1. Bashkir Medical State University

2. Bashkir Medical State University; CJSC “Optimedservice”

3. CJSC “Optimedservice”

4. City Clinical Hospital № 8

Abstract

The outcomes and complications of the coronavirus infection are of interest to specialists in many fields of medicine, including ophthalmologists.Purpose: to analyze the clinical features of ophthalmic complications in patients with coronavirus infection COVID-19.Materials and methods. Four patients aged 37 to 70 years with ophthalmic inflammatory complications with coronavirus infection were examined and treated.Results. In 2 cases, eye damage was observed in the acute phase of COVID infection. It included deep keratitis, iridocyclitis, and exacerbation of rhinosinusitis complicated by osteomyelitis, orbital phlegmon with loss of vision. In the remaining 2 cases, in the post-COVID period (2 and 5 months after the disease, respectively), acute dacryoadenitis with the dry eye syndrome and subacute episcleritis was observed. In addition to anti-COVID therapy, all patients underwent specific ophthalmic therapy, which in 1 case included surgical intervention.Conclusion. The cases presented demonstrate eye damage against the background of coronavirus infection with the involvement of various eye structures into the inflammatory process. The ophthalmological manifestations were severe, with complications in the acute phase of COVID and in the early post-COVID period. Clinical observations indicate the need for additional specific therapy of coronavirus infection complications, along with the basic anti-COVID treatment.

Publisher

Real Time, Ltd.

Reference16 articles.

1. Профилактика, диагностика и лечение новой коронавирусной инфекции (2019-n CoV). Временные методические рекомендации. Версия 1 (29.01.2020). Временные методические рекомендации. Диагностика, профилактика и лечение новой коронавирусной инфекции (COVID-19), версия 14 (27.12.2021) [Электронный ресурс]. Режим доступа: https://xn--80aesfpebagmfblc0a.xn--p1ai/ai/doc/1213/attach/vmr_COVID-19_V14_27-12-2021.pdf. Дата обращения: 02.06.2022.

2. Long B, Carius BM, Chavez S, et al. Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation. American Journal of Emergency Medicine. 2022 Apr; 54: 46–57. doi: 10.1016/j.ajem.2022.01.028

3. Ahmad Malik J, Ahmed S, Shinde M et al. The impact of COVID-19 on comorbidities: A review of recent updates for combating it. Saudi Journal of Biological Sciences. 2022 May; 29 (5): 3586–99. doi: 10.1016/j.sjbs.2022.02.006

4. Callaway E. What Omicron's BA.4 and BA.5 variants mean for the pandemic. Nature. 2022 Jun; 606 (7916): 848–9. doi: 10.1038/d41586-022-01730-y. PMID: 35750920

5. Majchuk D.Ju., Atlas S.N., Loshkareva A.O. Ocular manifestations of coronavirus infection COVID-19 (clinical observation). Vestnik oftal'mologii. 2020; 136 (4): 118–23 (In Russ.).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3